EGFR and head and neck cancer: PIT for advanced or locoregionally recurrent unresectable head and neck cancer (HNC-PIT) is a recently applied local method that targets EGFR on the surface of cancer cells, and although PIT for NPSCC has been practiced in Japan since September 2020, the results remain unclear.